Lost Money on GSK plc(GSK)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky
Portfolio Pulse from
Law firm Levi & Korsinsky has filed a class action securities lawsuit against GSK plc, alleging securities fraud related to the Zantac withdrawal. The lawsuit claims GSK misrepresented its knowledge about NDMA risks in Zantac between February 2020 and August 2022, suggesting the company knew about potential cancer risks for decades before removing the drug from the market.
March 20, 2025 | 4:45 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
The class action lawsuit could negatively impact GSK's stock price by raising concerns about potential financial liability and management credibility regarding Zantac's withdrawal.
The lawsuit alleges systematic misrepresentation about Zantac's risks, which could lead to potential financial penalties, reputational damage, and investor loss of confidence.
CONFIDENCE 90
IMPORTANCE 85
RELEVANCE 100